Rational identification of diet-derived postbiotics for improving intestinal microbiota function

Current Opinion in Biotechnology

Volumn 26, Issue , 2014, Pages 85-90

  Klemashevich, Cory ^a   Wu, Charmian ^b   Howsmon, Daniel ^a   Alaniz, Robert C ^c   Lee, Kyongbum ^b   Jayaraman, Arul ^a,c  

^a Texas AandM University   (United States)

^b Tufts University   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; PROBIOTICS;

BIOACTIVE MOLECULES; COMPUTATIONAL TOOLS; CROHN'S DISEASE; METABOLOMICS; MICROBIOTAS; PREBIOTICS; SYSTEMS BIOLOGY; WHOLE BODY;

RATIONAL FUNCTIONS;

ACETYLSALICYLIC ACID; FRUCTOSE OLIGOSACCHARIDE; NUTRACEUTICAL; POSTBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

BACTERIAL METABOLISM; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INTESTINE FLORA; INTESTINE INJURY; IRRITABLE COLON; LACTOBACILLUS CASEI; LOW DRUG DOSE; METABOLOMICS; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES COMPOSITION; STATISTICAL ANALYSIS; SYSTEMS BIOLOGY;

ANIMALS; DIET; HUMANS; INTESTINES; METABOLOMICS; MICROBIOTA; PREBIOTICS; PROBIOTICS; SYSTEMS BIOLOGY;

EID: 84887552846     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.10.006     Document Type: Review

References (55)

1. Tiihonen K., Ouwehand A.C., Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev 2010, 9:107-116.
2. Arora T., Sharma R. Fermentation potential of the gut microbiome: implications for energy homeostasis and weight management. Nutr Rev 2011, 69:99-106.
3. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
4. Kamada N., Chen G.Y., Inohara N., Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013, 14:685-690.
5. Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23:187-192.
6. Russell S.L., Gold M.J., Hartmann M., Willing B.P., Thorson L., Wlodarska M., Gill N., Blanchet M.-R., Mohn W.W., McNagny K.M., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 2012, 13:440-447.
7. Compare D., Coccoli P., Rocco A., Nardone O.M., De Maria S., Cartenì M., Nardone G. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2012, 22:471-476.
8. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009, 106:3698-3703.
9. Shen J., Obin M.S., Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013, 34:39-58.
10. Greenblum S., Turnbaugh P.J., Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A 2012, 109:594-599.
11. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
12. Arthur J.C., Perez-Chanona E., Mühlbauer M., Tomkovich S., Uronis J.M., Fan T.-J., Campbell B.J., Abujamel T., Dogan B., Rogers A.B., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338:120-123.
13. Ahmadi A., Milani E., Madadlou A., Mortazavi S., Mokarram R., Salarbashi D. Synbiotic yogurt-ice cream produced via incorporation of microencapsulated lactobacillus acidophilus (la-5) and fructooligosaccharide. J Food Sci Technol 2012, 1-7.
14. Sanders M.E., Heimbach J.T., Pot B., Tancredi D.J., Lenoir-Wijnkoop I., Lähteenmäki-Uutela A., Gueimonde M., Bañares S. Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2011, 2:127-133.
15. Talley N.J., Abreu M.T., Achkar J.-P., Bernstein C.N., Dubinsky M.C., Hanauer S.B., Kane S.V., Sandborn W.J., Ullman T.A., Moayyedi P. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011, 106:S2-S25.
16. Sartor R.B. Gut microbiota: diet promotes dysbiosis and colitis in susceptible hosts. Nat Rev Gastroenterol Hepatol 2012, 9:561-562.
17. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
18. Tlaskalova-Hogenova H., Stepankova R., Kozakova H., Hudcovic T., Vannucci L., Tuckova L., Rossmann P., Hrncir T., Kverka M., Zakostelska Z., et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011, 8:110-120.
19. Johnston B.C., Goldenberg J.Z., Vandvik P.O., Sun X., Guyatt G.H. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011, 11:CD004827.
20. Guglielmetti S., Mora D., Gschwender M., Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011, 33:1123-1132.
21. Endo H., Higurashi T., Hosono K., Sakai E., Sekino Y., Iida H., Sakamoto Y., Koide T., Takahashi H., Yoneda M., et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol 2011, 46:894-905.
22. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011, 108:16050-16055.
23. Rauch M., Lynch S.V. The potential for probiotic manipulation of the gastrointestinal microbiome. Curr Opin Biotechnol 2012, 23:192-201.
24. Neyrinck A.M., Van Hée V.F., Bindels L.B., De Backer F., Cani P.D., Delzenne N.M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br J Nutr 2013, 109:802-809.
25. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006, 157:876-884.
26. Yasuda A., Inoue K.-i, Sanbongi C., Yanagisawa R., Ichinose T., Tanaka M., Yoshikawa T., Takano H. Dietary supplementation with fructooligosaccharides attenuates allergic peritonitis in mice. Biochem Biophys Res Commun 2012, 422:546-550.
27. Campos D., Betalleluz-Pallardel I., Chirinos R., Aguilar-Galvez A., Noratto G., Pedreschi R. Prebiotic effects of yacon (Smallanthus sonchifolius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activity. Food Chem 2012, 135:1592-1599.
28. Soleimani N., Hoseinifar S.H., Merrifield D.L., Barati M., Abadi Z.H. Dietary supplementation of fructooligosaccharide (FOS) improves the innate immune response, stress resistance, digestive enzyme activities and growth performance of Caspian roach (Rutilus rutilus) fry. Fish Shellfish Immunol 2012, 32:316-321.
29. Lee Y.K., Low K.Y., Siah K., Drummond L.M., Gwee K.-A. Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile. Microb Ecol Health Dis 2012, 23:18572.
30. Da Silva L., Godejohann M., Martin F-PJ, Collino S., Bürkle A., Moreno-Villanueva M., Bernhardt J., Toussaint O., Grubeck-Loebenstein B., Gonos E.S., et al. High-resolution quantitative metabolome analysis of urine by automated flow injection NMR. Anal Chem 2013, 85:5801-5809.
31. Segata N., Haake S.K., Mannon P., Lemon K.P., Waldron L., Gevers D., Huttenhower C., Izard J. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012, 13:R42.
32. Hong P.-Y., Croix J.A., Greenberg E., Gaskins H.R., Mackie R.I. Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PLoS ONE 2011, 6:e25042.
33. Bolca S., Van de Wiele T., Possemiers S. Gut metabotypes govern health effects of dietary polyphenols. Curr Opin Biotechnol 2013, 24:220-225.
34. Guo Y., Mah E., Davis C.G., Jalili T., Ferruzzi M.G., Chun O.K., Bruno R.S. Dietary fat increases quercetin bioavailability in overweight adults. Mol Nutr Food Res 2013, 57:896-905.
35. van Duynhoven J., Vaughan E.E., Jacobs D.M., Kemperman R.A., van Velzen E.J., Gross G., Roger L.C., Possemiers S., Smilde A.K., Doré J., et al. Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A 2010, 108:4531-4538.
36. Marcobal A., Kashyap P.C., Nelson T.A., Aronov P.A., Donia M.S., Spormann A., Fischbach M.A., Sonnenburg J.L. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J 2013, 2013. 10.1038/ismej.2013.89.
37. Nemoto H., Kataoka K., Ishikawa H., Ikata K., Arimochi H., Iwasaki T., Ohnishi Y., Kuwahara T., Yasutomo K. Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci 2012, 57:2955-2964.
38. Bansal T., Alaniz R.C., Wood T.K., Jayaraman A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci U S A 2010, 107:228-233.
39. Ou J., Carbonero F., Zoetendal E.G., DeLany J.P., Wang M., Newton K., Gaskins H.R., O'Keefe S.J. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013, 98:111-120.
40. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., Harris H.M.B., Coakley M., Lakshminarayanan B., O'Sullivan O., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
41. Kok M.M., Ruijken M.A., Swann J., Wilson I., Somsen G., Jong G. Anionic metabolic profiling of urine from antibiotic-treated rats by capillary electrophoresis-mass spectrometry. Anal Bioanal Chem 2013, 405:2585-2594.
42. Antunes L.C., Han J., Ferreira R.B., Lolic P., Borchers C.H., Finlay B.B. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011, 55:1494-1500.
43. Want E.J., Cravatt B.F., Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 2005, 6:1941-1951.
44. Xiao J.F., Zhou B., Ressom H.W. Metabolite identification and quantitation in LC-MS/MS-based metabolomics. TrAC Trends Anal Chem 2012, 32:1-14.
45. Erickson A.R., Cantarel B.L., Lamendella R., Darzi Y., Mongodin E.F., Pan C., Shah M., Halfvarson J., Tysk C., Henrissat B., et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE 2012, 7:e49138.
46. Väremo L., Nookaew I., Nielsen J. Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front Physiol 2013, 4.
47. Sigurdsson M.I., Jamshidi N., Steingrimsson E., Thiele I., Palsson B.O. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst Biol 2010, 4.
48. Karlsson F.H., Nookaew I., Petranovic D., Nielsen J. Prospects for systems biology and modeling of the gut microbiome. Trends Biotechnol 2011, 29:251-258.
49. Borenstein E. Computational systems biology and in silico modeling of the human microbiome. Brief Bioinform 2012, 13:769-780.
50. Chen N., del Val I.J., Kyriakopoulos S., Polizzi K.M., Kontoravdi C. Metabolic network reconstruction: advances in in silico interpretation of analytical information. Curr Opin Biotechnol 2012, 23:77-82.
51. Heinken A., Sahoo S., Fleming R.M.T., Thiele I. Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes 2013, 4:28-40.
52. Moriya Y., Shigemizu D., Hattori M., Tokimatsu T., Kotera M., Goto S., Kanehisa M. PathPred: an enzyme-catalyzed metabolic pathway prediction server. Nucleic Acids Res 2010, 38:W138-W143.
53. Yousofshahi M., Lee K., Hassoun S. Probabilistic pathway construction. Metab Eng 2011, 13:435-444.
54. Ibrahim M., Anishetty S. A meta-metabolome network of carbohydrate metabolism: interactions between gut microbiota and host. Biochem Biophys Res Commun 2012, 428:278-284.
55. Muegge B.D., Kuczynski J., Knights D., Clemente J.C., González A., Fontana L., Henrissat B., Knight R., Gordon J.I. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011, 332:970-974.